IOL CHEMICALS & PHARM. | BH.IMMUN&BIO | IOL CHEMICALS & PHARM./ BH.IMMUN&BIO |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | -7.4 | - | View Chart |
P/BV | x | 1.5 | 1.4 | 106.3% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. BH.IMMUN&BIO |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
BH.IMMUN&BIO Mar-23 |
IOL CHEMICALS & PHARM./ BH.IMMUN&BIO |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 52 | 1,036.1% | |
Low | Rs | 272 | 21 | 1,327.8% | |
Sales per share (Unadj.) | Rs | 377.6 | 10.3 | 3,655.4% | |
Earnings per share (Unadj.) | Rs | 23.7 | -3.9 | -615.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -3.8 | -829.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 20.4 | 1,257.1% | |
Shares outstanding (eoy) | m | 58.71 | 43.18 | 136.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 3.5 | 30.6% | |
Avg P/E ratio | x | 17.1 | -9.4 | -181.9% | |
P/CF ratio (eoy) | x | 12.8 | -9.5 | -134.9% | |
Price / Book Value ratio | x | 1.6 | 1.8 | 89.0% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 1,561 | 1,521.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 151 | 1,110.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 446 | 4,970.1% | |
Other income | Rs m | 256 | 11 | 2,416.0% | |
Total revenues | Rs m | 22,427 | 457 | 4,910.8% | |
Gross profit | Rs m | 2,257 | -161 | -1,404.4% | |
Depreciation | Rs m | 462 | 2 | 23,080.0% | |
Interest | Rs m | 165 | 71 | 233.3% | |
Profit before tax | Rs m | 1,887 | -223 | -847.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -56 | -879.6% | |
Profit after tax | Rs m | 1,391 | -166 | -836.2% | |
Gross profit margin | % | 10.2 | -36.0 | -28.3% | |
Effective tax rate | % | 26.2 | 25.3 | 103.8% | |
Net profit margin | % | 6.3 | -37.3 | -16.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 358 | 2,699.9% | |
Current liabilities | Rs m | 5,025 | 940 | 534.4% | |
Net working cap to sales | % | 20.9 | -130.6 | -16.0% | |
Current ratio | x | 1.9 | 0.4 | 505.3% | |
Inventory Days | Days | 43 | 85 | 50.6% | |
Debtors Days | Days | 8 | 1,135 | 0.7% | |
Net fixed assets | Rs m | 11,017 | 1,262 | 873.1% | |
Share capital | Rs m | 587 | 432 | 136.0% | |
"Free" reserves | Rs m | 14,490 | 450 | 3,217.6% | |
Net worth | Rs m | 15,077 | 882 | 1,709.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 1,620 | 1,276.8% | |
Interest coverage | x | 12.5 | -2.2 | -578.2% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.3 | 389.2% | |
Return on assets | % | 7.5 | -5.9 | -127.2% | |
Return on equity | % | 9.2 | -18.9 | -48.9% | |
Return on capital | % | 13.6 | -17.2 | -78.9% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 14.5 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 65 | 0.0% | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 65 | 9,379.7% | |
Net fx | Rs m | -122 | -65 | 188.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 109 | 1,122.6% | |
From Investments | Rs m | -1,200 | 5 | -25,974.0% | |
From Financial Activity | Rs m | -41 | -147 | 27.9% | |
Net Cashflow | Rs m | -18 | -34 | 54.8% |
Indian Promoters | % | 48.2 | 59.3 | 81.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 40.8 | 127.1% | |
Shareholders | 130,003 | 35,313 | 368.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | BH.IMMUN&BIO | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.64% | -0.57% | -0.57% |
1-Month | 4.77% | -2.21% | 0.07% |
1-Year | -0.25% | 22.70% | 52.18% |
3-Year CAGR | -13.23% | -10.99% | 14.04% |
5-Year CAGR | 16.12% | 28.45% | 19.13% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the BH.IMMUN&BIO share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of BH.IMMUN&BIO the stake stands at 59.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of BH.IMMUN&BIO.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
BH.IMMUN&BIO paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of BH.IMMUN&BIO.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.